Markus Zeitlinger
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 116
- Antibiotics Pharmacokinetics and Efficacy 112
- Epidemiology 50
- Pneumonia and Respiratory Infections 19
- Co-authors
- Markus Müller (29 shared papers)Peter Marhofer (19 shared papers)Peter Matzneller (44 shared papers)Oliver Langer (49 shared papers)Christian Joukhadar (19 shared papers)Daniela Marhofer (17 shared papers)Martin Bauer (47 shared papers)Edith Lackner (32 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (36 papers)Antimicrobial Agents and Chemotherapy (29 papers)Clinical Pharmacokinetics (13 papers)International Journal of Antimicrobial Agents (12 papers)Clinical Microbiology and Infection (11 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Markus Zeitlinger
324 papers receiving 7.0k citations
Markus Zeitlinger's Hit Papers
Peers
Comparison fields: 5 of 143
- Molecular Medicine 975
- Applied Microbiology and Biotechnology 342
- Pharmacology 2.1k
- Clinical Biochemistry 446
- Infectious Diseases 1.0k
Countries citing papers authored by Markus Zeitlinger
This map shows the geographic impact of Markus Zeitlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Zeitlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Zeitlinger more than expected).
Fields of papers citing papers by Markus Zeitlinger
This network shows the impact of papers produced by Markus Zeitlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Zeitlinger. The network helps show where Markus Zeitlinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Zeitlinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 343 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# Hit paper breakdown → | 2020 | 678 |
| 2 | Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial Hit paper breakdown → | 2020 | 338 |
| 3 | Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey Hit paper breakdown → | 2020 | 299 |
| 4 | 2011 | 225 | |
| 5 | 2012 | 209 | |
| 6 | 2011 | 105 | |
| 7 | 2009 | 97 | |
| 8 | 2013 | 97 | |
| 9 | 2013 | 89 | |
| 10 | 2013 | 88 | |
| 11 | 2004 | 87 | |
| 12 | 2012 | 82 | |
| 13 | 2009 | 81 | |
| 14 | 2015 | 77 | |
| 15 | 2016 | 77 | |
| 16 | 2005 | 76 | |
| 17 | 2002 | 69 | |
| 18 | 2004 | 67 | |
| 19 | 2003 | 64 | |
| 20 | 2016 | 57 |
About Markus Zeitlinger
Markus Zeitlinger is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Oncology and Surgery, having authored 343 papers that have together received 7.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (112 papers), Drug Transport and Resistance Mechanisms (42 papers), Antibiotic Resistance in Bacteria (37 papers), Pharmacological Effects and Toxicity Studies (30 papers), Pneumonia and Respiratory Infections (19 papers), Antimicrobial Resistance in Staphylococcus (18 papers), Bacterial Identification and Susceptibility Testing (17 papers) and Antifungal resistance and susceptibility (16 papers). The work is most often cited by research in Molecular Medicine (975 citations), Applied Microbiology and Biotechnology (342 citations), Pharmacology (2.1k citations), Clinical Biochemistry (446 citations) and Infectious Diseases (1.0k citations). Markus Zeitlinger has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Markus Müller, Peter Marhofer, Peter Matzneller, Oliver Langer, Christian Joukhadar, Daniela Marhofer, Martin Bauer, Edith Lackner, Bernhard Fischer and Hendrik Fischer. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Clinical Pharmacokinetics, International Journal of Antimicrobial Agents and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.